Home latest Remdesivir is the first drug to show improvement in COVID-19 patients

Remdesivir is the first drug to show improvement in COVID-19 patients

The government said on Tuesday it has approved Gilead Sciences Inc’s antiviral drug remdesivir for emergency use in treating COVID-19 patients.

Remdesivir is the first drug to show improvement in COVID-19 patients in formal clinical trials. It was granted emergency use authorization by the US Food and Drug Administration last month and has received approval by Japanese health regulators.

“Remdesivir approved on June 1 under emergency use with condition for five dose administration,” the Drugs Controller General said in an email statement.

The drugmaker did not immediately respond to an email seeking further details.As of Tuesday, India has 198,706 cases of coronavirus and has recorded 5,598 deaths, health ministry data showed.

Gilead Sciences had on Monday reported that remdesivir showed modest benefit in patients with moderate COVID-19 given a five-day course, while those who received it for 10 days in the study did not fare as well.

European and South Korean authorities are also looking at remdesivir, with South Korean health authorities last Friday saying they would request imports of the drug. Gilead is yet to gain regulatory approval in either market.

Most Popular

KKR’s playoff chances handed a blow with defeat to CSK

Ravindra Jadeja slammed consecutive sixes off the last two balls of the match to take Chennai Super Kings (CSK) to a six-wicket win over...

Amazon reports 37% growth in sales, expects bumper holiday season

Ecommerce behemoth Amazon has reported better-than-expected Q3 results in the pandemic times when people tend to shop more online, as net sales increased 37...

Styris jokingly ‘wonders’ if Suryakumar Yadav would play for NZ

Former New Zealand all-rounder Scott Styris jokingly suggested that Suryakumar Yadav can move to New Zealand in case he wants to play international cricket. The...

Alphabet shares up after strong Q3 results over high ad growth

Google parent company Alphabet saw its stock rising as much as 9 percent as it posted strong results in its third-quarter earnings results amid...
FMIM Ad